TFR607 - MEDICAL PHARMACOLOGY of CARDIOVASCULAR SYSTEM
| Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
|---|---|---|---|---|---|---|
| MEDICAL PHARMACOLOGY of CARDIOVASCULAR SYSTEM | TFR607 | 1st Semester | 3 | 0 | 3 | 10 |
| Prequisites | ||||||
| Course language | Turkish | |||||
| Course type | Elective | |||||
| Mode of Delivery | Face-to-Face | |||||
| Learning and teaching strategies | Lecture Discussion Question and Answer | |||||
| Instructor (s) | Faculty members of the department | |||||
| Course objective | To study anatomy, physology and pharmacology of cardiovascular system, and drugs effect mechanisms on cardiovascular system and clinical pharmacology of drugs, effecting on cardiovascular system | |||||
| Learning outcomes |
| |||||
| Course Content | Antiarrhythmics, antianginal agents, antihypertensives, peripheral vasodilators, drugs used against heart failure, diuretics, hypolipidemic drugs, anticoagulants, antiplatelet agents, fibrinolytics, hemostatic drugs | |||||
| References | B.G. Katzung 2015 (Basic and Clinical Pharmacology) S.O. Kayaalp 2012 (Rasyonel tedavi yönünden Tıbbi Farmakoloji) Goodman & Gilmans The Pharmacological Basis of Therapeutics (12. baskı) | |||||
Course outline weekly
| Weeks | Topics |
|---|---|
| Week 1 | Antihypertensive drugs |
| Week 2 | Anti-anginal drugs |
| Week 3 | Antiarrhythmic drugs |
| Week 4 | Drugs used against heart failure |
| Week 5 | Beta-blockers |
| Week 6 | Peripheral vasodilators and angiogenic factors |
| Week 7 | Mid-term exam |
| Week 8 | Anticoagulant drugs |
| Week 9 | Antiplatelet and fibrinolytic drugs |
| Week 10 | Hypolipidemic drug |
| Week 11 | Vasoactive substances released from the endothelium |
| Week 12 | Clinical use of cardiovascular drugs I |
| Week 13 | Clinical use of cardiovascular drugs II |
| Week 14 | FINAL EXAM |
Assesment methods
| Course activities | Number | Percentage |
|---|---|---|
| Attendance | 0 | 0 |
| Laboratory | 0 | 0 |
| Application | 0 | 0 |
| Field activities | 0 | 0 |
| Specific practical training | 0 | 0 |
| Assignments | 0 | 0 |
| Presentation | 0 | 0 |
| Project | 0 | 0 |
| Seminar | 0 | 0 |
| Midterms | 1 | 40 |
| Final exam | 1 | 60 |
| Total | 100 | |
| Percentage of semester activities contributing grade succes | 0 | 40 |
| Percentage of final exam contributing grade succes | 0 | 60 |
| Total | 100 | |
WORKLOAD AND ECTS CALCULATION
| Activities | Number | Duration (hour) | Total Work Load |
|---|---|---|---|
| Course Duration (x14) | 14 | 3 | 42 |
| Laboratory | 0 | 0 | 0 |
| Application | 0 | 0 | 0 |
| Specific practical training | 0 | 0 | 0 |
| Field activities | 0 | 0 | 0 |
| Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 5 | 70 |
| Presentation / Seminar Preparation | 4 | 16 | 64 |
| Project | 0 | 0 | 0 |
| Homework assignment | 0 | 0 | 0 |
| Midterms (Study duration) | 1 | 44 | 44 |
| Final Exam (Study duration) | 1 | 80 | 80 |
| Total Workload | 34 | 148 | 300 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
| D.9. Key Learning Outcomes | Contrubition level* | ||||
|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | |
| 1. Follow current scientific developments in the field of pharmacology, design, execute and conclude an original scientific project. | X | ||||
| 2. Follow and use new information, computational and technological developments in education, practice and research related to pharmacology. | X | ||||
| 3. Have basic information about drug interactions, side effects and toxic effects of drugs. | X | ||||
| 4. Demonstrate lifelong learning behaviour by making use of scientific and technological innovations for professional and social changes. | X | ||||
| 5. In daily clinical practice, can collect clinical data related to the safety of medicines, track the problems encountered in drug administration, identify responsible reasons and take necessary precautions. | X | ||||
| 6. Evaluate the ethical appropriateness of a scientific research project, review project files and write reports by participating the ethical committee. | X | ||||
| 7. Can provide training, consultancy and supervision in the field of biopharmaceuticals and health. | X | ||||
| 8. Prepare scientific reports and presentations on a subject related to pharmacology. | X | ||||
| 9. Evaluate scientific, economic and legal steps in the process until a molecule becomes a drug. | X | ||||
| 10. Can design and execute an experimental setup in a laboratory environment and analyse the data obtained. | X | ||||
| 11. By interpreting and writing a resulted original research that contributes to science, brings innovation and develops a new scientific method, publish it in prestigious scientific journals with national and / or international referees. | X | ||||
| 12. Has technical skills to perform basic manipulation and practices in experimental animals. | X | ||||
| 13. Can share scientific information at the international level and use critical thinking skills personally and professionally. | X | ||||
| 14. Evaluate and compare the results of drug treatments applied in the field of public health and deduce fair and rational results for the public benefit from this comparison. By using the knowledge on health related science fields and public problems, can offer new approaches and alternative solutions. | X | ||||
| 15. Records the information flow and activities in the field of professional activity correctly, understandably and securely. At national or international institutions participated, fulfills its professional responsibilities within the framework of professional values, ethical principles and legal regulations, without discrimination. | X | ||||
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest